Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-03-07

Clinical Trial Update: Magnitude of Changes in 25 OH Vitamin D3 Levels After Vitamin D3 Supplementation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating changes in 25-hydroxyvitamin D3 levels after Vitamin D3 supplementation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Vitamin D Deficiency | Phase 1, Phase 2 | Status: WITHDRAWN